From the Indiana University School of Medicine, Indianapolis, IN.
Female Pelvic Med Reconstr Surg. 2021 Nov 1;27(11):667-671. doi: 10.1097/SPV.0000000000001042.
The objective of this study is to determine if an ERAS (enhanced recovery after surgery) protocol enhanced the patient-perceived postdischarge recovery after laparoscopic sacrocolpopexy.
In this prospective cohort study, patients exposed to an ERAS protocol completed a preoperative survey that included established predictors of postdischarge recovery. Postoperatively, they completed the validated Postdischarge Surgical Recovery 13 (PSR-13) scale at 7, 14, and 42 days. A historical cohort of non-ERAS patients who completed similar surveys were included for comparisons. Characteristics between the 2 cohorts were analyzed using the χ2 test, Student t tests, and Mann-Whitney U tests where appropriate. A mixed-design analysis of variance model was constructed to determine if our ERAS protocol affected recovery as measured by the PSR-13 scale.
Eighty-nine ERAS patients were compared with 169 non-ERAS controls. There were no differences in established predictors of recovery between the groups. Length of hospital stay was shorter in the ERAS cohort (33±13.1 hours vs 44.2±25.9 hours; mean difference, 11.2; 95% confidence interval [CI], 6.44-16.0). Postdischarge recovery significantly improved with time (7 days: 52.7; 95% CI, 50.1-55.2; 14 days: 63.4; 95% CI, 60.9-65.8; 42 days: 80.1, 95% CI, 78.1-82.1). The ERAS cohort reported greater postdischarge recovery than the non-ERAS cohort (as measured by the PSR-13 scale) at postoperative days 7, 14, and 42 days (68.4 vs 62.3; mean difference, 6.1; 95% CI, 2.04-10.16).
Enhanced recovery after surgery protocols reduce length of hospital stay and enhance patient-perceived postdischarge recovery.
本研究旨在确定术后加速康复(ERAS)方案是否能改善腹腔镜骶骨阴道固定术后患者出院后的恢复感知。
在这项前瞻性队列研究中,接受 ERAS 方案的患者在术前完成了一项调查,其中包括出院后恢复的既定预测因素。术后,他们在第 7、14 和 42 天分别使用验证后的术后恢复 13 项量表(PSR-13)进行评估。同时纳入了完成类似调查的非 ERAS 患者的历史队列进行比较。使用卡方检验、学生 t 检验和曼-惠特尼 U 检验分析两组间的特征,必要时使用混合设计方差模型来确定我们的 ERAS 方案是否会影响 PSR-13 量表所衡量的恢复情况。
89 例 ERAS 患者与 169 例非 ERAS 对照组进行了比较。两组间恢复的既定预测因素无差异。ERAS 组的住院时间更短(33±13.1 小时 vs 44.2±25.9 小时;平均差异,11.2;95%置信区间 [CI],6.44-16.0)。出院后恢复随时间显著改善(第 7 天:52.7;95% CI,50.1-55.2;第 14 天:63.4;95% CI,60.9-65.8;第 42 天:80.1,95% CI,78.1-82.1)。ERAS 组在术后第 7、14 和 42 天的报告中,其出院后恢复优于非 ERAS 组(通过 PSR-13 量表衡量)(68.4 比 62.3;平均差异,6.1;95% CI,2.04-10.16)。
术后加速康复方案可缩短住院时间,提高患者出院后的恢复感知。